🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was designed to investigate the 1 year efficacy and safety of th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-06
Trial ID
NCT00929110
Treatments Being Tested
This is a Phase IV multi-center, randomized, open-label, cross-over, placeb...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-21
Trial ID
NCT02786927
This study assessed the efficacy and safety of indacaterol (150 µg once dai...
Status
Completed
Location
Novartis Investigator Site
Start Date
2009-03
Trial ID
NCT00846586
Treatments Being Tested
This study assessed the efficacy and safety of indacaterol (150 µg once dai...
Status
Completed
Location
Novartis Investigator Site
Start Date
2009-04
Trial ID
NCT00877383
Treatments Being Tested
This is a randomized, multi-centre, open-label, placebo-device, cross-over ...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-12-30
Trial ID
NCT02982187
Treatments Being Tested
This study assessed the effect of QVA149 on patient-reported dyspnea in mod...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-10
Trial ID
NCT01490125
Treatments Being Tested
The purpose of this study is to provide pivotal efficacy and safety data fo...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-09
Trial ID
NCT01202188
This study is being done to examine the influence of Tiotropium (good or ba...
Status
Completed
Location
Mayo Clinic
Start Date
2006-10
Trial ID
NCT00578968
Treatments Being Tested
Stage 1 of the study is designed to provide data about the risk-benefit of ...
Status
Completed
Location
Pinnacle Research Group, LLC
Start Date
2007-04
Trial ID
NCT00463567
This study will assess the efficacy and safety of QVA149 compared to tiotro...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-05
Trial ID
NCT01574651
Treatments Being Tested